{"organizations": [], "uuid": "7629ba2aa9ef0b6bdc1d12fb10e80a4f51e2df2e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-northeast-pharmaceutical-group-see/brief-northeast-pharmaceutical-group-sees-fy-2017-net-profit-up-360-pct-to-400-pct-idUSL4N1PR4NI", "country": "US", "domain_rank": 408, "title": "BRIEF-Northeast Pharmaceutical Group sees FY 2017 net profit up 360 pct to 400 pct", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.966, "site_type": "news", "published": "2018-02-01T21:22:00.000+02:00", "replies_count": 0, "uuid": "7629ba2aa9ef0b6bdc1d12fb10e80a4f51e2df2e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-northeast-pharmaceutical-group-see/brief-northeast-pharmaceutical-group-sees-fy-2017-net-profit-up-360-pct-to-400-pct-idUSL4N1PR4NI", "ord_in_thread": 0, "title": "BRIEF-Northeast Pharmaceutical Group sees FY 2017 net profit up 360 pct to 400 pct", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-northeast pharmaceutical group", "sentiment": "negative"}, {"name": "reuters) - northeast pharmaceutical group co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - Northeast Pharmaceutical Group Co Ltd\n* Says it sees net profit for FY 2017 to increase by 360 percent to 400 percent, or to be 110 million yuan to 120 million yuan\n* Says the net profit of FY 2016 was 23.8 million yuan\n* Comments that increased vitamin C price as main reason for the forecast\nSource text in Chinese: goo.gl/V1o1yT\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/V1o1yT"], "published": "2018-02-01T21:22:00.000+02:00", "crawled": "2018-02-02T13:06:37.059+02:00", "highlightTitle": ""}